RRML - Fecal microbiota transplantation in recurrent Clostridium difficile infection: the first prospective study of 30 patients in Romania
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- November 2018 -
 
Fungi in human pathology - are... 12
Phenotypic and genotypic varia... 8
Expanding PVL positive MRSA He... 7
Multiplex ligation dependent p... 5
Benefits of cytogenetic testin... 4
Evaluation of antioxidant, ant... 4
Associations of vascular calci... 4
Romanian Review of Laboratory ... 3
Correlation of chronic periodo... 3
The utility of molecular genet... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 26(2)/2018 DOI:10.2478/rrlm-2018-0013
XML
TXT

Research article

Fecal microbiota transplantation in recurrent Clostridium difficile infection: the first prospective study of 30 patients in Romania

Mihaela Laszlo, Oliviu Pascu, Daniel-Corneliu Leucuta, Vasile Andreica

Correspondence should be addressed to: Mihaela Laszlo

Abstract:

Introduction: The infection with Clostridium difficile has increased in incidence worldwide and it raises many problems with regard to therapy, resistance to treatment and especially recurrence. Recurrence is frequent in patients treated for Clostridium difficile infection, requiring vancomycin by mouth, with limited alternatives. The literature shows that one of the most efficient treatment methods in Clostridium difficile infection is the transplantation of gut microbiota, also known as fecal microbiota transplantation. Aim: We present our results following FMT performed in patients with recurrent Clostridium difficile infection, and propose a simple and effective protocol for fecal microbiota transplantation. Study design: The study was prospective. The phases of the FMT procedure: assessment of patient eligibility, patient’s consent, identification and screening of donors, discontinuation of antibiotics (vancomycin, metronidazole) 3 days prior to the procedure. Methods: Between 2013 and 2015, FMT was performed in 30 patients with recurrent Clostridium difficile infection, by direct infusion of extensively processed donor fecal matter via colonoscopy. We followed up the patients for 12 months. Results: Immediate post-transplantation outcome in what concerns stool frequency during the follow-up period (7 days) was encouraging in 93.33% of patients. The donors were healthy individuals (53% 1st degree relatives), previously screened for possible infections and infestations. This result was sustained at 6-month and 12-month follow-up. Post-transplantation recurrence occurred in 6.67% (2 patients), which responded well to treatment and did not require a new vancomycin course. Conclusions: Fecal microbiota transplantation via colonoscopy is effective, safe, easy to perform, it yields lasting results and is therefore a good option for recurrent or treatment-resistant Clostridium difficile infection.

Keywords: Clostridium difficile, recurrence, fecal transplantation, donor

Received: 1.12.2017
Accepted: 14.3.2018
Published: 19.3.2018

 
  PDF Download full text PDF
(372 KB)
     
 
How to cite
Laszlo M, Pascu O, Leucuta DC, Andreica V. Fecal microbiota transplantation in recurrent Clostridium difficile infection: the first prospective study of 30 patients in Romania. Rev Romana Med Lab. 2018;26(2):201-10. DOI:10.2478/rrlm-2018-0013